2dd8

From Proteopedia

---

Revision as of 19:24, 12 November 2007

proteopedia linkproteopedia link

spinqualitylabelsall models 2dd8, resolution 2.30Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody

Contents 1 Overview 2 Disease 3 About this Structure 4 Reference

Overview

The severe acute respiratory syndrome coronavirus (SARS-CoV, or SCV), which caused a world-wide epidemic in 2002 and 2003, binds to a receptor, angiotensin-converting enzyme 2 (ACE2), through the receptor-binding, domain (RBD) of its envelope (spike, S) glycoprotein. The RBD is very, immunogenic; it is a major SCV neutralization determinant and can elicit, potent neutralizing antibodies capable of out-competing ACE2. However, the, structural basis of RBD immunogenicity, RBD-mediated neutralization, and, the role of RBD in entry steps following its binding to ACE2 have not been, elucidated. By mimicking immune responses with the use of RBD as an, antigen to screen a large human antibody library derived from healthy, volunteers, we identified a novel potent cross-reactive SCV-neutralizing, monoclonal antibody, m396, which competes with ACE2 for binding to RBD, and determined the crystal structure of the RBD-antibody complex at 2.3-A, resolution. The antibody-bound RBD structure is completely defined, revealing two previously unresolved segments (residues 376-381 and, 503-512) and a new disulfide bond (between residues 378 and 511)., Interestingly, the overall structure of the m396-bound RBD is not, significantly different from that of the ACE2-bound RBD. The antibody, epitope is dominated by a 10-residue-long protruding beta6-beta7 loop with, two putative ACE2-binding hotspot residues (Ile-489 and Tyr-491). These, results provide a structural rationale for the function of a major, determinant of SCV immunogenicity and neutralization, the development of, SCV therapeutics based on the antibody paratope and epitope, and a, retrovaccinology approach for the design of anti-SCV vaccines. The, available structural information indicates that the SCV entry may not be, mediated by ACE2-induced conformational changes in the RBD but may involve, other conformational changes or/and yet to be identified coreceptors.

Disease

Known disease associated with this structure: Agammaglobulinemia OMIM:[147020]

About this Structure

2DD8 is a Protein complex structure of sequences from Homo sapiens and Human sars coronavirus with NAG and PO4 as ligands. Full crystallographic information is available from OCA.

Reference

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody., Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS, J Biol Chem. 2006 Jun 9;281(23):15829-36. Epub 2006 Apr 5. PMID:16597622

Page seeded by OCA on Mon Nov 12 21:31:04 2007